4//SEC Filing
Rothfuss Cristin 4
Accession 0000950170-25-032758
CIK 0000873303other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:00 PM ET
Size
5.1 KB
Accession
0000950170-25-032758
Insider Transaction Report
Form 4
Rothfuss Cristin
EVP, General Counsel
Transactions
- Tax Payment
Common Stock
2025-03-03$103.77/sh−391$40,574→ 13,621 total
Footnotes (2)
- [F1]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.
- [F2]Amount of Securities Beneficially Owned includes 195 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0002046214
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:00 PM ET
- Size
- 5.1 KB